Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Scynexis Inc (NQ: SCYX )

7.450 USD -0.280 (-3.62%)
Official Closing Price Updated: 6:25 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 228,200
Open 7.630
Bid (Size) 7.280 (1)
Ask (Size) 7.880 (5)
Prev. Close 7.730
Today's Range 7.250 - 7.790
52wk Range 4.201 - 10.40
Shares Outstanding 20,622,778
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SCYNEXIS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
SCYNEXIS Announces Positive Results from Interim Analyses of Ongoing Phase 3 Studies (FURI and CARES), Demonstrating Oral Ibrexafungerp's Ability to Treat Severe Fungal Infections in the Hospital Sett
From GlobeNewswire News Releases

Performance

YTD
+3.91%
+3.91%
1 Month
-14.56%
-14.56%
3 Month
-4.61%
-4.61%
6 Month
+49.00%
+49.00%
1 Year
-26.96%
-26.96%

More News

Read More
SCYNEXIS to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
From GlobeNewswire News Releases
SCYNEXIS and Amplity Health Announce Agreement to Support the Anticipated U.S. Commercialization of BrexafemmeTM (Ibrexafungerp) for Vaginal Yeast Infections
From GlobeNewswire News Releases
UTILITY Therapeutics Joins Antimicrobials Working Group
From PR Newswire
SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
From GlobeNewswire News Releases
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags Top Gainers Pre/Market Outlook NTEC
From Benzinga
SCYNEXIS and Hansoh Pharma Announce Licensing Agreement and Strategic Partnership for Ibrexafungerp in Greater China
From Business Wire News Releases
Week in Review: $1.2 Billion in China Life Science Deals, IPOs and Financings
From ChinaBio® Today
Hansoh Announces $122 Million Agreement to Acquire Rights to Antifungal
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.